HomeNewsBusinessCompaniesNatco Pharma challenges patent on Tamiflu
Trending Topics
Sensex Live
Coforge Share Price
Shyam Dhani Industries IPO
KSH International Shares
Gold Rate Today

Natco Pharma challenges patent on Tamiflu

Natco Pharma has challenged a patent on Tamiflu (Oseltamivir Phosphate)—a drug used in the treatment of bird and swine-flu infections, reports the PTI.

February 11, 2011 / 17:54 IST
Story continues below Advertisement
Remove Ad

Natco Pharma has challenged a patent on Tamiflu (Oseltamivir Phosphate)

first published: Feb 11, 2011 05:52 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Follow Us On: Facebook twitter instagram linkedin youtube
Trending Topics
Sensex Today Coforge Share Price Ola Electric Share Price Gold Rate Today Silver Price Today Vijay Hazare Trophy Ganesh Uike Train Fare Hike news Sheikh Hasina Udaipur gang rape
News
Business Markets Stocks India News City News Economy Mutual Funds Personal Finance IPO News Startups
Markets
Home Currencies Commodities Pre-Market IPO Global Market Bonds
Personal Finance
Home Loans up to 50 Lakhs Credit Cards Lifetime Free Finance Tracker New Fixed Deposits Fixed Deposit Comparison Fixed Income
Mutual Funds
Home MC 30 Top Ranked Funds ETFs Mutual Fund Screener
Tools
Income Tax Calculator EMI Calculator Retirement Planning Gratuity Calculator Petrol Price in India Diesel Price in India IFSC Code
Community
Stock Markets
Network 18 Sites
News18 Firstpost CNBC TV18 News18 Hindi Cricketnext Overdrive
Quick Links
About Us Contact Us Advisory Alert Advertise with Us Disclaimer Privacy Policy Cookie Policy Terms & Conditions Financial Terms (Glossary) Sitemap Investors
Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.